Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Intresting to see if they reveal who bought deal is by? Will it be oversubscribed?
Not great, but maybe best deal to add stability for now and move forward.
Lots of catalysts still between now and year end.
10 to 40$ a share possible if buyout.
Breast Cancer, Pancreatic Cancer P3 announcement around September 20th, CAR-T BD possible announcement, Colorectal, Pancreatic and Anal Cancer Data in October. Asian Deal with Adlai Nortye P3 in Breast cancer triggers 80 million dollar payment.
Depending on which ones are good news/ vs bad news or don't work.
But lots of catalysts to move forward.
Announcement could come at anytime. BE READY. Good luck everyone. I'm already up a lot here so don't care reallly it's all free money for me. $$$$$$$$$$$$$$$$$$
Sorry been too busy. I own way too many shares of this but been buying for a long time. Pretty happy with share price movement and PanCan announcement. Good Luck everyone
Been buying lots more during quiet time and thinking myself as being crazy.
Quiet time might be over hopefully.
My sources weren't too accurate predicting some movement in past unfortunate but I kept buying hoping for the best. Call me crazy and you'd be accurate there.
Good luck with this one everyone hopefully we're pulling in the big score this time round.
Unless you follow this really closely you wouldn't know. Heh heh.... Lol.
News next week it looks like.
Profit is always nice good for you. I'm in for longer term. Hopefully good announcement next week GL everyone.
Looks like buying has started hopefully.
GL everyone.
**** January 10***** Watch this date.
Rumor of a big investor taking a serious look at ONCY. Guy is worth 200 million plus. Not a sure thing at all but January 10th he'll make his decision he says. Good luck everyone.
Yep saw all that man. We're getting close to biga biga deal mon....
Buyout very possible. Roche's Tecentriq and Pelareorep could be used for Pancreatic and possibly breast cancer now, and maybe much more. Surprised no mention of CAR-T in last quarterly report.
Maybe Roche is going for Pancreatic, Breast and some sort of CAR-T deal???
Freaking complicated. Wish it was simpler.
Wanna get rich fast. ??
Buyout by Roche now pretty much in the bag. Just a matter of price and when and how rich we get. Good luck everybody.
Friend of a Friend says something is happening at Roche Headquarters over next couple of weeks. Not sure if we'll have a deal by Christmas or not. Good luck everyone let's all get freaking rich.
Yes Buyout is coming, but do is Christmas.
Bad joke lol.
Going through a bunch of research and junk reading, couple new gems in there possibly
Possibility of new Brokerage recommendations or updated ones next week. Looking forward to being rich GLTA.
Buyout Buyout Buyout coming soon.
KOL meeting Monday 14th. GL
Everyone.
Possible News next week. Stay tuned!!!!!!
Good luck everyone. Hopefully buyout by end ov November??
Two new BOD
Parsons , Negotiated Trillion buyout with Pfizer last year.
2. Rigby added recently as well has experience selling Biotechs.
3. No treatments for Pancreatic Cancer and their Roche Goblet results 3/3 patients responded. That never never happens in Pancreatic cancer. Lots of buzz around Pancreatic Trial in medical circles.
4. My spider senses are tingling....... says buyout coming.
GL everyone. Nice uptick today but still time to buy .
Rumors of something big possibly next week?? I'm batting 0% so far on my Rumors so take it with a grain of salt....
Im pretty happy so far up 40% on my big buy so far. Holding until buyout in a couple months. GL everyone.
Easy money, probably volatile. Choose you entry point carefully if you don't have a position. Buyout in 30-90 days for big $$
GL everyone.
Monday should be interesting. Unusual that there have been no analyst updates yet. They are buying for their own accounts before they release new updated reports trust me. I've seen this all before. GL everyone.
Get onboard the gravy train!!! Easy money!!
11 August Thursday is an important day.
Hopefully they'll comment on the Pancreatic trial with Roche. That's the big money ?? GL.
Looking forward to August 14th quarterly.
Hopefully we'll get a good update on Pancreatic cancer data.
Looks like we're in the money. Should be a very interesting week. Good luck everyone.
Pancreatic cancer might just be our way into the big leagues !!!!! Awesome sauce!!!!!!
New director has obviously been brought on board to help with Oncolytics Negotiations in a deal with Pfizer.
Buyout by end of August or first two weeks of September for at least $30 US a share that's my call. Just a guess but that's how I see it.
Novartis rumor. They're taking closer look at CAR-T data maybe. They would need to make an up front payment, milestones and
give ONCY a percentage of the CAR-T treatment. Sounds like a big ask on ONCY part. But who knows. ONCY might deal lower to get a deal done? Since share price struggling.
Thought for sure there would be some leaked info or rumors on the Dark Stock Web on Oncolytics Biotech , but it's been strangely quiet. Maybe just bad overall market spooked everyone. Hoping fir a good week next week.
Hopefully something good released. I'm batting zero on my rumor mill so far.
Heard nothing new on DSW this week.
Something might be happening next week.
No details just chatter on special board for elite stock membership. Don't read much into this but might want to watch the stock closely. I only have this info as third party so take with a grain of salt. It could end up being nothing like last time but with everything that happened last week I might take some profit off if we get a spike.
Sorry if this is just another pain in a** post.
https://pharmaboardroom.com/interviews/carsten-lu-ceo-adlai-nortye-china/
2019 interview with CEO. You have to register to get full interview but there's some good info there. He says in interview that they aren't going into breast cancer because space is " Too crowded"
That's pretty interesting because there deep into that now and it might be a big win for them? and for us in USA and Europe.
Phase III study by end of year In USA Europe and Asia should move the stock big time if it happens.
I think a buyout may happen this year as well. The thing that confuses me about this stock is that so many different big Pharmas have trials going on with it. That's kind of unusual. Maybe giving virus to people is too complicated for investors to understand.
I'm still trying to wrap my head around it too actually. We are just coming through a virus pandemic that brought the whole world to a standstill. If we could somehow harness that power and direct it against cancer it could be groundbreaking.
Ya my friend bought a bunch at 4 something and then bunch more at almost 6 CDN. He's not too happy but feeling better with latest news.
I know some people in Healthcare and they have never heard of it. They work on Cancer ward too and are barely making it through some days. They said something like this if it works would be pretty close to miraculous if it can be given IV and no special biohazard precautions required.
I bought a bit too much portfolio % wise broke my 10% rule on this one. We'll see what happens.
Ya hate to repeat it because I think it's garbage. He did tell me to look at trades on Canadian side for Thursday. I don't have access to a trade workstation to see all the trades for the day. Trading was up on the Canadian side though for Thursday. Not sure this helps anyone sorry man.
RUMOR OF ANNOUNCEMENT COMING NEXT WEEK. APPARENTLY THAT'S WHAT CAUSED THURSDAY SPIKE. NOT GOING TO POST WHAT I HEARD CAN'T CONFIRM ANYTHING. JUST A HEADS UP.
Gilead C47 drug trial halted FDA by. Positive news on Pelareorep with same combo!!!!!!!!@
- 15 Dec 2021--- Treatment with intravenous pelareorep plus azacitidine reduced tumor burden ------------------------------------------------------
26 Jan 2022--- Gilead Announces Partial Clinical Hold for Studies Evaluating Magrolimab in Combination With Azacitidine.
Other posts that may be responsible for uptick recently.
https://www.entrepreneur.com/article/413987
https://chicagotoday.news/world-nation/this-under-the-radar-biotech-stocks-latest-move-could-be-2022s-best-play-usa-news-group/
https://www.fiercebiotech.com/research/stop-sugarcoating-cancer-cells-to-empower-car-t-therapy-solid-tumors
Strong speculation that there may be follow up to their CAR-T/ Pelareorep that cured 7 out of 7 cancers in mice last Feb 17.
Good luck to all I've been loading up big time on yhis since end of Dec.